I blogged about IP protection in genetics on a blog post at the World Economic Forum’s website. As part of our genetics council at the forum, we came up with a whitepaper that is linked with the blog. The whitepaper and blog look at both sides of the puzzle of creating an envelope of exclusivity and creating an environment for biotech to flourish. The path may be somewhere in the middle.
Read it on the forum blog and let me know what you think.
http://forumblog.org/2012/08/is-it-ethical-to-try-to-patent-a-gene/
-anu
Ms Anu Acharya is the co-founder and CEO of Mapmygenome, a company that pioneered the field of personalised, preventive healthcare by making personal genomics tools available to the masses. With a vision to “Touch 100 million lives”, Mapmygenome was established in 2013, heralding the advent of improved healthcare through genomics-based personalised, precision medicine starting with India and other neglected populations.
Under her leadership, the company has been achieving several milestones, awards and honours. From the ET startup Awards to NASSCOM Emerge 50, WSJ’s Top global startups’ award, Red Herring Asia and Global to the recently conferred Pride of Telangana award; Mapmygenome has certainly become a force to be reckoned with.
A fiercely respected entrepreneur, she also serves as a governing board member and/or mentor for various high profile institutions such as the NIBMG, NIAB, IIITHyderabad, IvyCap Ventures, CSIR and ABLE. She is also a distinguished alumna from IIT Kharagpur.
Janampatri to Genomepatri - Anu Acharya 